tiprankstipranks
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
PremiumPress ReleasesAIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
10d ago
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
PremiumPress Releases
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
14d ago
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
PremiumPress Releases
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
15d ago
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
PremiumPress ReleasesAIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
28d ago
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
PremiumPress Releases
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
1M ago
AIM ImmunoTech announces publication of findings from Ampligen study
PremiumThe Fly
AIM ImmunoTech announces publication of findings from Ampligen study
1M ago
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
PremiumPress ReleasesAIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
1M ago
AIM ImmunoTech Announces Launch of CEO Corner Platform
PremiumPress Releases
AIM ImmunoTech Announces Launch of CEO Corner Platform
2M ago
AIM ImmunoTech launches CEO Corner platform
PremiumThe Fly
AIM ImmunoTech launches CEO Corner platform
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100